Fundz

Neurovalens raises £2.1M in funding and gains FDA approval for anxiety treatment wearable device

PRIVATEApr 08, 2024

Amount Raised

£2.1 Million

Round Type

Seed

BelfastManufacturingBiotechnologyHealth CareMedicalMedical Device

Investors

Existing Investors

Description

Belfast-based healthtech company Neurovalens announced that it has closed a £2.1 million funding round with existing investors and gained FDA approval for its Modius Stress device, designed to treat anxiety by delivering noninvasive electrical stimulation to the head.

Company Information

Company

Neurovalens

Location

Belfast, Northern Ireland, United Kingdom

About

Neurovalens is a healthtech company based in Belfast, specializing in combining neuroscience and technology to tackle global health challenges. It has developed medical devices designed to deliver noninvasive electrical stimulation to key areas of the brain and nervous system without the need for surgically implanted electrodes.

Fundz sees it the moment Neurovalens raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Neurovalens's next move

See what Strategic adds

Neurovalens raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.